Waystar CEO to Speak at Canaccord Genuity Growth Conference

LEHI, Utah and LOUISVILLE, Ky., Aug. 9, 2024 /PRNewswire/ — Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will speak at the Canaccord Genuity Growth Conference on Tuesday, August 13, 2024, at 10:00 a.m. ET.

The presentation will be viewable live on Waystar’s Investor Relations website at https://investors.waystar.com/news-events/events. A recording will be available on the site afterward.

About Waystar

Waystar’s mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 18 of 22 institutions on the U.S. News Best Hospitals list. Waystar’s enterprise-grade platform annually processes over 5 billion healthcare payment transactions, including over $1.2 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.

Investor Contact
Sandy Draper
investors@waystar.com
502-238-9511

Media Contact
Kristin Lee
kristin.lee@waystar.com 

View original content:https://www.prnewswire.com/news-releases/waystar-ceo-to-speak-at-canaccord-genuity-growth-conference-302219173.html

SOURCE Waystar

Staff

Recent Posts

Orange Auto Insurance, Inc., Subsidiary of HPN Holdings, Inc. Announces Reinsurance Partnership

Chicago, Illinois--(Newsfile Corp. - February 5, 2026) - HPN Holdings, Inc. (OTCID: KICK) ("HPN" or…

14 minutes ago

Sacred Connection Launches Comprehensive Educational Guide to Traditional Rapé Medicine

In the newly-released educational guide What Is Rapé?, Sacred Connection covers essential topics around Rapé…

2 hours ago

Endomimetics Announces Strategic Restructuring into IP Foundry to Accelerate Bionanomatrix(TM) Clinical Applications

Accelerating platform-driven clinical innovation across vascular, neurovascular, and cardiovascular applications through a centralized Bionanomatrix™ IP…

2 hours ago

Tenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected Revenues

Fourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over…

2 hours ago

Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging

Cellular findings show Telomir-Zn modulates intracellular metal balance linked to oxidative stress, mitochondrial dysfunction, DNA…

2 hours ago